Publication:
Results of cisplatin, adriamycin and etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer

dc.contributor.buuauthorBilgin, Tufan
dc.contributor.buuauthorOzan, Hakan
dc.contributor.buuauthorKara, H. Filiz
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentKadın Hastalıkları ve Doğum Ana Bilim Dalı
dc.contributor.scopusid7004103925
dc.contributor.scopusid7003908072
dc.contributor.scopusid36845105800
dc.date.accessioned2023-08-08T11:24:48Z
dc.date.available2023-08-08T11:24:48Z
dc.date.issued2004
dc.description.abstractThe efficacy of the combination treatment of cisplatin, adriamycin and etoposide were retrospectively evaluated in 26 recurrent or metastatic endometrial cancer patients. One hundred and twenty-three treatment courses were observed. Patients received 20 mg/m(2) cisplatin and 80 mg/m(2) etoposide by continuous IV infusion for three days and adriamycin 40 mg/m(2) IV the second day. Treatment courses were repeated every four weeks. Megestrol acetate, 160 mg/day, was added in six patients who had positive progesterone receptors. Ten (38.5%) women had complete and three (11.5%) patients had partial response with an overall response rate of 50%. Median follow-up was 24 months. Surviving patients were alive for four months and six years. Toxicity was mainly hematological and gastrointestinal ulcerations and stomatitis were also observed.
dc.identifier.citationBilgin, T. vd. (2004). “Results of cisplatin, adriamycin and etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer”. European Journal of Gynaecological Oncology, 25(3), 379-380.
dc.identifier.endpage380
dc.identifier.issn0392-2936
dc.identifier.issue3
dc.identifier.pubmed15171324
dc.identifier.scopus2-s2.0-2342525248
dc.identifier.startpage379
dc.identifier.urihttps://www.imrpress.com/journal/ejgo/25/3/pii/2004187
dc.identifier.urihttp://hdl.handle.net/11452/33403
dc.identifier.volume25
dc.identifier.wos000221429600025
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherMRE Press
dc.relation.journalEuropean Journal of Gynaecological Oncology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectObstetrics and gynecology
dc.subjectEndometrial cancer
dc.subjectChemotherapy
dc.subjectCisplatin
dc.subjectAdriamycin
dc.subjectEtoposide
dc.subjectMedroxyprogesterone acetate
dc.subjectAdenocarcinoma
dc.subjectCyclophosphamide
dc.subject5-Fluorouracil
dc.subjectDoxorubicin
dc.subjectPaclitaxel
dc.subjectEpirubicin
dc.subjectCarcinoma
dc.subjectRegimen
dc.subject.emtreeAdult
dc.subject.emtreeAged
dc.subject.emtreeAnemia
dc.subject.emtreeArticle
dc.subject.emtreeBlood toxicity
dc.subject.emtreeCancer combination chemotherapy
dc.subject.emtreeCancer localization
dc.subject.emtreeClinical article
dc.subject.emtreeClinical trial
dc.subject.emtreeControlled clinical trial
dc.subject.emtreeControlled study
dc.subject.emtreeDiarrhea
dc.subject.emtreeDigestive system ulcer
dc.subject.emtreeDrug efficacy
dc.subject.emtreeEndometrium cancer
dc.subject.emtreeFemale
dc.subject.emtreeFever
dc.subject.emtreeGastrointestinal hemorrhage
dc.subject.emtreeHuman
dc.subject.emtreeMelena
dc.subject.emtreeMetastasis
dc.subject.emtreeNeutropenia
dc.subject.emtreeRecurrent cancer
dc.subject.emtreeStomatitis
dc.subject.emtreeSurvival time
dc.subject.emtreeThrombocytopenia
dc.subject.emtreeCisplatin
dc.subject.emtreeDoxorubicin
dc.subject.emtreeEtoposide
dc.subject.emtreeMegestrol acetate
dc.subject.meshAdult
dc.subject.meshAntineoplastic combined chemotherapy protocols
dc.subject.meshCisplatin
dc.subject.meshDoxorubicin
dc.subject.meshEndometrial neoplasms
dc.subject.meshEtoposide
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMedical records
dc.subject.meshMiddle aged
dc.subject.meshNeoplasm metastasis
dc.subject.meshNeoplasm recurrence, local
dc.subject.meshRetrospective studies
dc.subject.meshSurvival analysis
dc.subject.meshTreatment outcome
dc.subject.meshTurkey
dc.subject.scopusSentinel Lymph Node; Endometrial Neoplasms; Cancer Staging
dc.subject.wosOncology
dc.subject.wosObstetrics and gynecology
dc.titleResults of cisplatin, adriamycin and etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer
dc.typeArticle
dc.wos.quartileQ4
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Kadın Hastalıkları ve Doğum Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: